Pharmaceuticals - Community Register

  

List of refusals for human medicinal products

Masican

Product name: Masican
Active substance: Masitinib
Indication: Masican is indicated for the treatment of unresectable and/or metastatic malignant gastrointestinal stromal tumour (GIST) in adults after progression with imatinib treatment.
Marketing Authorisation Holder: AB Science S.A.

European Commission proceduresGoto top of the page

Close date procedure Procedure type EMEA number Decision summary publ decision docs annex
08/07/2014 Centralised - Refusal of marketing authorisation EMEA/H/C/2670 (2014)4843 of 04/07/2014